About this Journal Submit a Manuscript Table of Contents
Depression Research and Treatment
Volume 2012 (2012), Article ID 275957, 11 pages
http://dx.doi.org/10.1155/2012/275957
Review Article

Bipolar Disorder: Clinical Perspectives and Implications with Cognitive Dysfunction and Dementia

1Psychiatry Service, Hospital de São João (HSJ), EPE, 4200-319 Porto, Portugal
2Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal

Received 15 September 2011; Revised 13 March 2012; Accepted 27 March 2012

Academic Editor: Bernhard Baune

Copyright © 2012 R. Lopes and L. Fernandes. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. O'Brien, “Dementia associated with psychiatric disorders,” International Psychogeriatrics, vol. 17, no. 1, pp. S207–S221, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. V. Kessing and F. M. Nilsson, “Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses,” Journal of Affective Disorders, vol. 73, no. 3, pp. 261–269, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. G. Gildengers, M. A. Butters, K. Seligman et al., “Cognitive functioning in late-life bipolar disorder,” American Journal of Psychiatry, vol. 161, no. 4, pp. 736–738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Y. Tsai, H. C. Lee, C. C. Chen, and Y. L. Huang, “Cognitive impairment in later life in patients with early-onset bipolar disorder,” Bipolar Disorders, vol. 9, no. 8, pp. 868–875, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Huxley and R. J. Baldessarini, “Disability and its treatment in bipolar disorder patients,” Bipolar Disorders, vol. 9, no. 1-2, pp. 183–196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Burdick, J. F. Goldberg, and M. Harrow, “Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15 year follow-up,” Acta Psychiatrica Scandinavica, vol. 122, no. 6, pp. 499–506, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. P. Wingo, P. D. Harvey, and R. J. Baldessarini, “Neurocognitive impairment in bipolar disorder patients: functional implications,” Bipolar Disorders, vol. 11, no. 2, pp. 113–125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Martino, S. A. Strejilevich, M. Scápola et al., “Heterogeneity in cognitive functioning among patients with bipolar disorder,” Journal of Affective Disorders, vol. 109, no. 1-2, pp. 149–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Tabares-Seisdedos, V. Balanza-Martinez, J. Sanchez-Moreno, et al., “Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up,” Journal of Affective Disorders, vol. 109, no. 3, pp. 286–299, 2008.
  10. G. M. Goodwin, A. Martinez-Aran, D. C. Glahn, and E. Vieta, “Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report,” European Neuropsychopharmacology, vol. 18, no. 11, pp. 787–793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. F. Goldberg and K. N. R. Chengappa, “Identifying and treating cognitive impairment in bipolar disorder,” Bipolar Disorders, vol. 11, no. 2, pp. 123–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Dixon, E. Kravariti, C. Frith, R. M. Murray, and P. K. McGuire, “Effect of symptoms on executive function in bipolar illness,” Psychological Medicine, vol. 34, no. 5, pp. 811–821, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Quraishi and S. Frangou, “Neuropsychology of bipolar disorder: a review,” Journal of Affective Disorders, vol. 72, no. 3, pp. 209–226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Rubinsztein, A. Michael, E. S. Paykel, and B. J. Sahakian, “Cognitive impairment in remission in bipolar affective disorder,” Psychological Medicine, vol. 30, no. 5, pp. 1025–1036, 2000.
  15. A. Martínez-Arán, E. Vieta, F. Colom et al., “Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome,” Bipolar Disorders, vol. 6, no. 3, pp. 224–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Martínez-Arán, E. Vieta, M. Reinares et al., “Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder,” American Journal of Psychiatry, vol. 161, no. 2, pp. 262–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. I. J. Torres, V. G. Boudreau, and L. N. Yatham, “Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis,” Acta Psychiatrica Scandinavica, vol. 116, no. 434, pp. 17–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. L. J. Robinson and I. N. Ferrier, “Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence,” Bipolar Disorders, vol. 8, no. 2, pp. 103–116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Simonsen, K. Sundet, A. Vaskinn et al., “Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction,” Bipolar Disorders, vol. 10, no. 2, pp. 245–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L. N. Yatham, I. J. Torres, G. S. Malhi et al., “The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC),” Bipolar Disorders, vol. 12, no. 4, pp. 351–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Clark, A. Sarna, and G. M. Goodwin, “Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression,” American Journal of Psychiatry, vol. 162, no. 10, pp. 1980–1982, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. I. N. Ferrier, R. Chowdhury, J. M. Thompson, S. Watson, and A. H. Young, “Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: a preliminary report,” Bipolar Disorders, vol. 6, no. 4, pp. 319–322, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Daban, A. Martinez-Aran, C. Torrent et al., “Specificity of cognitive deficits in bipolar disorder versus schizophrenia: a systematic review,” Psychotherapy and Psychosomatics, vol. 75, no. 2, pp. 72–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Wolf, M. Brüne, and H. J. Assion, “Theory of mind and neurocognitive functioning in patients with bipolar disorder,” Bipolar Disorders, vol. 12, no. 6, pp. 657–666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. G. S. Malhi, J. Lagopoulos, P. Das, K. Moss, M. Berk, and C. M. Coulston, “A functional MRI study of Theory of Mind in euthymic bipolar disorder patients,” Bipolar Disorders, vol. 10, no. 8, pp. 943–956, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Vieta, A. Martinez-Aran, and J. Goldberg, “Cognition across the life span: clinical implications for older adults with bipolar disorder,” in Cognitive Dysfunction in Bipolar Disorder: A Guide for Clinicians, J. Goldberg and K. Burdick, Eds., pp. 235–255, American Psychiatric Press, Washington, DC, USA, 2008.
  27. L. J. Robinson, J. M. Thompson, P. Gallagher et al., “A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder,” Journal of Affective Disorders, vol. 93, no. 1–3, pp. 105–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Martinez-Aran, C. Torrent, R. Tabares-Seisdedos et al., “Neurocognitive impairment in bipolar patients with and without history of psychosis,” Journal of Clinical Psychiatry, vol. 69, no. 2, pp. 233–239, 2008. View at Scopus
  29. R. Tabares-Seisdedos, V. Balanza-Martinez, J. Salazar-Fraile, G. Selva-Vera, C. Leal-Cercos, and M. Gomez-Beneyto, “Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis,” Journal of Psychiatric Research, vol. 37, no. 6, pp. 479–486, 2003.
  30. E. Bora, M. Yücel, C. Pantelis, and M. Berk, “Meta-analytic review of neurocognition in bipolar II disorder,” Acta Psychiatrica Scandinavica, vol. 123, no. 3, pp. 165–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. H. Ha, K. Ha, J. H. Kim, and J. E. Choi, “Regional brain gray matter abnormalities in patients with bipolar II disorder: a comparison study with bipolar I patients and healthy controls,” Neuroscience Letters, vol. 456, no. 1, pp. 44–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. O. C. Chaves, L. E. Lombardo, C. E. Bearden et al., “Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study,” Bipolar Disorders, vol. 13, no. 1, pp. 118–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. F. C. Murphy and B. J. Sahakian, “Neuropsychology of bipolar disorder.,” The British Journal of Psychiatry. Supplement, vol. 41, pp. s120–s127, 2001. View at Scopus
  34. J. Godard, S. Grondin, P. Baruch, and M. F. Lafleur, “Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder,” Psychiatry Research, vol. 190, no. 2-3, pp. 244–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. L. V. Kessing and P. K. Andersen, “Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?” Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 12, pp. 1662–1666, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Balanzá-Martínez, G. Selva, A. Martínez-Arán et al., “Neurocognition in bipolar disorders—a closer look at comorbidities and medications,” European Journal of Pharmacology, vol. 626, no. 1, pp. 87–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Mur, M. J. Portella, A. Martínez-Arán, J. Pifarré, and E. Vieta, “Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients,” Journal of Clinical Psychiatry, vol. 69, no. 5, pp. 712–719, 2008. View at Scopus
  38. M. Berk, P. Conus, F. Kapczinski et al., “From neuroprogression to neuroprotection: implications for clinical care,” Medical Journal of Australia, vol. 193, no. 4, pp. S36–S40, 2010. View at Scopus
  39. M. Berk, F. Kapczinski, A. C. Andreazza et al., “Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors,” Neuroscience and Biobehavioral Reviews, vol. 35, no. 3, pp. 804–817, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Berk, K. T. Hallam, and P. D. McGorry, “The potential utility of a staging model as a course specifier: a bipolar disorder perspective,” Journal of Affective Disorders, vol. 100, no. 1–3, pp. 279–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Berk, “Neuroprogression: pathways to progressive brain changes in bipolar disorder,” International Journal of Neuropsychopharmacology, vol. 12, no. 4, pp. 441–445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Vieta, “Psychosocial consequences,” in Managing Bipolar Disorder in Clinical Practice, E. Vieta, Ed., pp. 9–14, Current Medicine Group, 2009.
  43. F. Kapczinski, E. Vieta, A. C. Andreazza et al., “Allostatic load in bipolar disorder: implications for pathophysiology and treatment,” Neuroscience and Biobehavioral Reviews, vol. 32, no. 4, pp. 675–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Balanzá-Martínez, R. Tabarés-Seisdedos, G. Selva-Vera et al., “Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study,” Psychotherapy and Psychosomatics, vol. 74, no. 2, pp. 113–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Zanelli, A. Reichenberg, K. Morgan et al., “Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations,” American Journal of Psychiatry, vol. 167, no. 1, pp. 78–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Akiskal, O. Pinto, and D. Lara, “Bipolarity in the setting of dementia: bipolar type VI?” Medscape Family Medicine/Primary Care, 2005.
  47. B. Ng, A. Camacho, D. R. Lara, M. G. Brunstein, O. C. Pinto, and H. S. Akiskal, “A case series on the hypothesized connection between dementia and bipolar spectrum disorders: Bipolar type VI?” Journal of Affective Disorders, vol. 107, no. 1–3, pp. 307–315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Dorey, O. Beauchet, C. T. Anterion et al., “Behavioral and psychological symptoms of dementia and bipolar spectrum disorders: review of the evidence of a relationship and treatment implications,” CNS Spectrums, vol. 13, no. 9, pp. 796–803, 2008. View at Scopus
  49. L. V. Kessing, L. Søndergård, J. L. Forman, and P. K. Andersen, “Lithium treatment and risk of dementia,” Archives of General Psychiatry, vol. 65, no. 11, pp. 1331–1335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. O. P. Almeida and S. Fenner, “Bipolar disorder: Similarities and differences between patients with illness onset before and after 65 years of age,” International Psychogeriatrics, vol. 14, no. 3, pp. 311–322, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. G. B. Cassano, S. L. McElroy, K. Brady, W. A. Nolen, and G. F. Placidi, “Current issues in the identification and management of bipolar spectrum disorders in 'special populations',” Journal of Affective Disorders, vol. 59, no. 1, pp. S69–S79, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Senanarong, J. L. Cummings, L. Fairbanks et al., “Agitation in alzheimer's disease is a manifestation of frontal lobe dysfunction,” Dementia and Geriatric Cognitive Disorders, vol. 17, no. 1-2, pp. 14–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Masouy, G. Chopard, P. Vandel et al., “Bipolar disorder and dementia: where is the link?” Psychogeriatrics, vol. 11, no. 1, pp. 60–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Velakoulis, M. Walterfang, R. Mocellin, C. Pantelis, and C. McLean, “Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases,” British Journal of Psychiatry, vol. 194, no. 4, pp. 298–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. D. Woolley, B. K. Khan, N. K. Murthy, B. L. Miller, and K. P. Rankin, “The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease,” Journal of Clinical Psychiatry, vol. 72, no. 2, pp. 126–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. N. Pavuluri, A. West, S. K. Hill, K. Jindal, and J. A. Sweeney, “Neurocognitive function in pediatric bipolar disorder: 3-year follow-up shows cognitive development lagging behind healthy youths,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 48, no. 3, pp. 299–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Yu, Z. Zhang, Y. Shi et al., “Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese han,” Journal of Clinical Psychiatry, vol. 69, no. 7, pp. 1104–1111, 2008. View at Scopus
  58. K. E. Burdick, B. Funke, J. F. Goldberg et al., “COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance,” Bipolar Disorders, vol. 9, no. 4, pp. 370–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. F. B. Dickerson, J. J. Boronow, C. Stallings et al., “The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder,” Bipolar Disorders, vol. 8, no. 2, pp. 124–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. D. C. Glahn, L. Almasy, M. Barguil et al., “Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families,” Archives of General Psychiatry, vol. 67, no. 2, pp. 168–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. I. J. Torres, V. G. DeFreitas, C. M. DeFreitas et al., “Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode,” Journal of Clinical Psychiatry, vol. 71, no. 9, pp. 1234–1242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. J. K. Zubieta, P. Huguelet, L. E. Ohl et al., “High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates,” American Journal of Psychiatry, vol. 157, no. 10, pp. 1619–1628, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Watson, J. M. Thompson, J. C. Ritchie, I. N. Ferrier, and A. H. Young, “Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function,” Bipolar Disorders, vol. 8, no. 1, pp. 85–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Osher, Y. Bersudsky, H. Silver, B. A. Sela, and R. H. Belmaker, “Neuropsychological correlates of homocysteine levels in euthymic bipolar patients,” Journal of Affective Disorders, vol. 105, no. 1–3, pp. 229–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. S. M. El-Badri, C. Heather Ashton, P. Brian Moore, V. Richard Marsh, and I. Nicol Ferrier, “Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder,” Bipolar Disorders, vol. 3, no. 2, pp. 79–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. T. W. J. Moorhead, J. McKirdy, J. E. D. Sussmann et al., “Progressive gray matter loss in patients with bipolar disorder,” Biological Psychiatry, vol. 62, no. 8, pp. 894–900, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. R. M. Post, A. M. Speer, C. J. Hough, and G. Xing, “Neurobiology of bipolar illness: implications for future study and therapeutics,” Annals of Clinical Psychiatry, vol. 15, no. 2, pp. 85–94, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. C. H. Chen, J. Suckling, B. R. Lennox, C. Ooi, and E. T. Bullmore, “A quantitative meta-analysis of fMRI studies in bipolar disorder,” Bipolar Disorders, vol. 13, no. 1, pp. 1–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. F. Benedetti, M. Absinta, M. A. Rocca, et al., “Tract-specific white matter structural disruption in patients with bipolar disorder,” Bipolar Disorders, vol. 13, no. 4, pp. 414–424, 2011.
  70. C. E. Bearden, K. M. Hoffman, and T. D. Cannon, “The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review,” Bipolar Disorders, vol. 3, no. 3, pp. 106–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Krabbendam, A. Honig, J. Wiersma et al., “Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission,” Acta Psychiatrica Scandinavica, vol. 101, no. 4, pp. 274–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Delaloye, G. Moy, S. Baudois et al., “Cognitive features in euthymic bipolar patients in old age,” Bipolar Disorders, vol. 11, no. 7, pp. 735–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. R. C. Young, C. F. Murphy, M. Heo, H. C. Schulberg, and G. S. Alexopoulos, “Cognitive impairment in bipolar disorder in old age: literature review and findings in manic patients,” Journal of Affective Disorders, vol. 92, no. 1, pp. 125–131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. M. F. Joseph, T. W. Frazier, E. A. Youngstrom, and J. C. Soares, “A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 18, no. 6, pp. 595–605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Gorwood, “Confusing clinical presentations and differential diagnosis of bipolar disorder,” Encephale, vol. 30, no. 2, pp. 182–193, 2004. View at Scopus
  76. K. E. Burdick, C. J. Endick, and J. F. Goldberg, “Assessing cognitive deficits in bipolar disorder: are self-reports valid?” Psychiatry Research, vol. 136, no. 1, pp. 43–50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. M. E. Wylie, B. H. Mulsant, B. G. Pollock et al., “Age at onset in geriatric bipolar disorder: effects on clinical presentation and treatment outcomes in an inpatient sample,” American Journal of Geriatric Psychiatry, vol. 7, no. 1, pp. 77–83, 1999. View at Scopus
  78. J. Goldberg, “Adverse cognitive effects of psychotropic medications,” in Cognitive Dysfunction in Bipolar Disorder: A Guide for Clinicians, J. Goldberg and K. Burdick, Eds., pp. 137–158, American Psychiatric Press, Washington, DC, USA, 2008.
  79. M. K. Holmes, K. Erickson, D. A. Luckenbaugh et al., “A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression,” Bipolar Disorders, vol. 10, no. 7, pp. 806–815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. K. J. Meador, D. W. Loring, P. G. Ray et al., “Differential cognitive and behavioral effects of carbamazepine and lamotrigine,” Neurology, vol. 56, no. 9, pp. 1177–1182, 2001. View at Scopus
  81. A. P. Aldenkamp, J. Arends, H. P. R. Bootsma et al., “Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers,” Epilepsia, vol. 43, no. 1, pp. 19–26, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. C. Daban, A. Martínez-Arán, C. Torrent et al., “Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results,” Journal of Clinical Psychopharmacology, vol. 26, no. 2, pp. 178–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. M. C. Salinsky, D. Storzbach, D. C. Spencer, B. S. Oken, T. Landry, and C. B. Dodrill, “Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers,” Neurology, vol. 64, no. 5, pp. 792–798, 2005. View at Scopus
  84. S. Frangou, S. Donaldson, M. Hadjulis, S. Landau, and L. H. Goldstein, “The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates,” Biological Psychiatry, vol. 58, no. 11, pp. 859–864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. L. L. Altshuler, J. Ventura, W. G. Van Gorp, M. F. Green, D. C. Theberge, and J. Mintz, “Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects,” Biological Psychiatry, vol. 56, no. 8, pp. 560–569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Z. Mintzer and R. R. Griffiths, “Lorazepam and scopolamine: a single-dose comparison of effects on human memory and attentional processes,” Experimental and Clinical Psychopharmacology, vol. 11, no. 1, pp. 56–72, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. I. Amado-Boccara, N. Gougoulis, M. F. P. Littre, A. Galinowski, and H. Loo, “Effects of antidepressants on cognitive functions: a review,” Neuroscience and Biobehavioral Reviews, vol. 19, no. 3, pp. 479–493, 1995. View at Publisher · View at Google Scholar · View at Scopus
  88. A. W. Zobel, S. Schulze-Rauschenbach, O. C. Von Widdern et al., “Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment,” Journal of Psychiatric Research, vol. 38, no. 4, pp. 377–383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. R. S. E. Keefe, M. Poe, T. M. Walker, J. W. Kang, and P. D. Harvey, “The schizophrenia cognition rating scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity,” American Journal of Psychiatry, vol. 163, no. 3, pp. 426–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. K. H. Nuechterlein, M. F. Green, R. S. Kern et al., “The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity,” American Journal of Psychiatry, vol. 165, no. 2, pp. 203–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. R. S. Kern, K. H. Nuechterlein, M. F. Green et al., “The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization,” American Journal of Psychiatry, vol. 165, no. 2, pp. 214–220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. M. F. Green, K. H. Nuechterlein, R. S. Kern et al., “Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study,” American Journal of Psychiatry, vol. 165, no. 2, pp. 221–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. K. E. Burdick, T. E. Goldberg, B. A. Cornblatt et al., “The MATRICS consensus cognitive battery in patients with bipolar i disorder,” Neuropsychopharmacology, vol. 36, no. 8, pp. 1587–1592, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Sajatovic, “Treatment of bipolar disorder in older adults,” International Journal of Geriatric Psychiatry, vol. 17, no. 9, pp. 865–873, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. D. N. Juurlink, M. M. Mamdani, A. Kopp, P. A. Rochon, K. I. Shulman, and D. A. Redelmeier, “Drug-induced lithium toxicity in the elderly: a population-based study,” Journal of the American Geriatrics Society, vol. 52, no. 5, pp. 794–798, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. E. Tsaltas, D. Kontis, V. Boulougouris, and G. N. Papadimitriou, “Lithium and cognitive enhancement: leave it or take it?” Psychopharmacology, vol. 202, no. 1–3, pp. 457–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. J. M. Meinhold, L. M. Blake, L. J. Mini, J. A. Welge, M. Schwiers, and A. Hughes, “Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia,” Drugs and Aging, vol. 22, no. 7, pp. 615–626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. P. N. Tariot, L. S. Schneider, J. E. Mintzer et al., “Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial,” Current Therapeutic Research-Clinical and Experimental, vol. 62, no. 1, pp. 51–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  99. J. F. Goldberg, “Treatment guidelines: current and future management of bipolar disorder,” Journal of Clinical Psychiatry, vol. 61, no. 13, pp. 12–18, 2000. View at Scopus
  100. J. R. Ellis, K. A. Ellis, C. F. Bartholomeusz et al., “Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans,” International Journal of Neuropsychopharmacology, vol. 9, no. 2, pp. 175–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. F. F. Erskine, J. R. Ellis, K. A. Ellis et al., “Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans,” Human Psychopharmacology, vol. 19, no. 7, pp. 503–509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Akhondzadeh, M. Gerami, M. Noroozian et al., “A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 8, pp. 1810–1815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. B. Fagerlund, B. Soholm, A. Fink-Jensen, H. Lublin, and B. Y. Glenthoj, “Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study,” Clinical Neuropharmacology, vol. 30, no. 1, pp. 3–12, 2007.
  104. T. Kelly, “Is donepezil useful for improving cognitive dysfunction in bipolar disorder?” Journal of Affective Disorders, vol. 107, no. 1–3, pp. 237–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. V. V. Dias, S. Brissos, and J. M. Gorman, “Adjuvant galantamine for cognitive dysfunction in a patient with bipolar disorder,” Journal of Psychiatric Practice, vol. 12, no. 5, pp. 327–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. E. Schrauwen and S. N. Ghaemi, “Galantamine treatment of cognitive impairment in bipolar disorder: four cases,” Bipolar Disorders, vol. 8, no. 2, pp. 196–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. U. Ehrt, F. Fritze, and D. Aarsland, “Mania after administration of cholinesterase inhibitors in patients with dementia and comorbid bipolar disorder: two case reports,” Journal of Clinical Psychopharmacology, vol. 31, no. 2, pp. 254–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. J. A. Lieberman, K. Papadakis, J. Csernansky et al., “A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia,” Neuropsychopharmacology, vol. 34, no. 5, pp. 1322–1329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. R. W. Buchanan, D. C. Javitt, S. R. Marder et al., “The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments,” American Journal of Psychiatry, vol. 164, no. 10, pp. 1593–1602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. U. Heresco-Levy, D. C. Javitt, R. Ebstein et al., “D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia,” Biological Psychiatry, vol. 57, no. 6, pp. 577–585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. T. T. Chei and F. N. Demetrio, “Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder,” Revista Brasileira de Psiquiatria, vol. 28, no. 3, pp. 252–254, 2006. View at Scopus
  112. A. H. Young, P. Gallagher, S. Watson, D. Del-Estal, B. M. Owen, and I. N. Ferrier, “Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder,” Neuropsychopharmacology, vol. 29, no. 8, pp. 1538–1545, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. R. E. Scheffer, R. A. Kowatch, T. Carmody, and A. J. Rush, “Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium,” American Journal of Psychiatry, vol. 162, no. 1, pp. 58–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. E. Lydon and R. S. El-Mallakh, “Naturalistic long-term use of methylphenidate in bipolar disorder,” Journal of Clinical Psychopharmacology, vol. 26, no. 5, pp. 516–518, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. D. C. Turner, L. Clark, E. Pomarol-Clotet, P. McKenna, T. W. Robbins, and B. J. Sahakian, “Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia,” Neuropsychopharmacology, vol. 29, no. 7, pp. 1363–1373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  116. K. E. Burdick, R. J. Braga, J. F. Goldberg, and A. K. Malhotra, “Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy,” CNS Drugs, vol. 21, no. 12, pp. 971–981, 2007. View at Publisher · View at Google Scholar · View at Scopus
  117. A. R. Hipkiss, J. E. Preston, D. T. M. Himswoth, V. C. Worthington, and N. J. Abbot, “Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells,” Neuroscience Letters, vol. 238, no. 3, pp. 135–138, 1997. View at Publisher · View at Google Scholar · View at Scopus
  118. T. Deckersbach, A. A. Nierenberg, R. Kessler et al., “Cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms,” CNS Neuroscience and Therapeutics, vol. 16, no. 5, pp. 298–307, 2010. View at Publisher · View at Google Scholar · View at Scopus